Literature DB >> 16012297

Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.

Shandra Bipat1, Saffire S K S Phoa, Otto M van Delden, Patrick M M Bossuyt, Dirk J Gouma, Johan S Laméris, Jaap Stoker.   

Abstract

OBJECTIVE: To compare ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) in the diagnosis and determination of resectability of pancreatic adenocarcinoma.
METHODS: Articles reporting US, CT, or MRI data of patients with known or suspected pancreatic adenocarcinoma and at least 20 patients verified with histopathology, surgical findings, or follow-up were included. A bivariate random effects approach was used to calculate sensitivity and specificity for diagnosis and resectability of pancreatic adenocarcinoma.
RESULTS: Sixty-eight articles fulfilled all inclusion criteria. For diagnosis, sensitivities of helical CT, conventional CT, MRI, and US were 91%, 86%, 84%, and 76% and specificities were 85%, 79%, 82%, and 75% respectively. Sensitivities for MRI and US were significantly lower compared with helical CT (P = 0.04 and P = 0.0001). For determining resectability, sensitivities of helical CT, conventional CT, MRI, and US were 81%, 82%, 82, and 83% and specificities were 82%, 76%, 78%, and 63% respectively. Specificity of US was significantly lower compared with helical CT (P = 0.011).
CONCLUSIONS: Helical CT is preferable as an imaging modality for the diagnosis and determination of resectability of pancreatic adenocarcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 16012297     DOI: 10.1097/01.rct.0000164513.23407.b3

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  65 in total

1.  An MRI-driven practice: a new perspective on MRI for the evaluation of adenocarcinoma of the head of the pancreas.

Authors:  Elliot B Tapper; Diego Martin; N Volkan Adsay; David Kooby; Bobby Kalb; Juan M Sarmiento
Journal:  J Gastrointest Surg       Date:  2010-05-14       Impact factor: 3.452

2.  Contrast enhanced endoscopic ultrasound: More than just a fancy Doppler.

Authors:  Rachid M Mohamed; Brian M Yan
Journal:  World J Gastrointest Endosc       Date:  2010-07-16

3.  Preoperative staging of cancer of the pancreatic head: is there room for improvement?

Authors:  Kristopher P Croome; Shiva Jayaraman; Christopher M Schlachta
Journal:  Can J Surg       Date:  2010-06       Impact factor: 2.089

Review 4.  [Combined PET-MRI of the abdomen].

Authors:  Tibor Vag; M Eiber; M Schwaiger
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

Review 5.  Indications for staging laparoscopy in pancreatic cancer.

Authors:  Antonella De Rosa; Iain C Cameron; Dhanwant Gomez
Journal:  HPB (Oxford)       Date:  2015-11-18       Impact factor: 3.647

6.  Which imaging modalities should be used for biliary strictures of unknown aetiology?

Authors:  Dirk Domagk; Johannes Wessling; Beate Conrad; Roman Fischbach; Christina Schleicher; Werner Böcker; Norbert Senninger; Achim Heinecke; Walter Heindel; Wolfram Domschke; Torsten Kucharzik
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

7.  Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability.

Authors:  Vyacheslav I Egorov; Roman V Petrov; Elena N Solodinina; Gregory G Karmazanovsky; Natalia S Starostina; Natalia A Kuruschkina
Journal:  World J Gastrointest Surg       Date:  2013-04-27

Review 8.  Investigation of abdominal pain to detect pancreatic cancer.

Authors:  J Ashley Guthrie; Maria B Sheridan
Journal:  BMJ       Date:  2008-05-10

9.  Predicting distant metastasis in patients with suspected pancreatic and periampullary tumors for selective use of staging laparoscopy.

Authors:  Annelie Slaar; Wietse J Eshuis; Niels A van der Gaag; C Yung Nio; Olivier R C Busch; Thomas M van Gulik; Johannes B Reitsma; Dirk J Gouma
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 10.  [Indications for magnetic resonance imaging in Internal Medicine. When do we really need this technology?].

Authors:  A G Schreyer; K Debl; H Herfarth
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.